Biocon Biologics: Biocon subsidiary grants distribution of biosimilar to Sandoz in Japan
NEW DELHI: Biocon Biologics, a subsidiary of Biocon has signed a distribution agreement with Sandoz, granting the company exclusive rights to promote, sell and distribute `Adalimumab BS for subcutaneous injection [FKB]’* in Japan.Based on this, Viatris has completed marketing and promotion of the product as of December 15, but will continue to provide transition support … Read more